Key Clinical Message
- Top of page
- Key Clinical Message
- Case Study
- Conflict of Interest
Traumatic intracranial internal carotid artery dissection is a rare but significant cause of stroke in patients in their forties, leading to high morbidity and mortality. Simultaneous ischemic stroke and optic nerve infarction can occur. Clinical suspicion of dissection is determining in the acute management.
- Top of page
- Key Clinical Message
- Case Study
- Conflict of Interest
The internal carotid artery dissection (ICAD), as a cause of stroke, is infrequent yet significant, being responsible for 20% of ischemic strokes in patients under 50 years of age [1-4]. It can occur at both the intracraneal and extracranial level. However, the former localization is much less common than the latter .
The incidence of ICAD is estimated to be about 1.7 per 100,000 inhabitants per year [6, 7], it can be spontaneous or traumatic, the first being common in older individuals of 50 years while the second occurs in younger patients (about 40 years) . ICAD of traumatic origin is rare; its incidence though still unknown, however, is estimated at around 0.08% .
The etiology of ICAD is multifactorial, and the pathophysiology is not completely understood. However, there are intrinsic and extrinsic factors that contribute to its development and predispose an individual. Intrinsic susceptibility of an individual is given by the existence of certain anomalies of the arterial wall (fibromuscular dysplasia, dilated aortic root, hyperdistensibility of the arterial wall, or endothelial dysfunction), or by genetic predisposition, less than 2% of cases of dissections have been associated with monogenic connective tissue disease (Ehlers Danlos syndrome, Marfan syndrome, polycystic kidney disease, deficiency of alpha-1 antitrypsin and hereditary hemochromatosis) [4, 6, 10-15]. The proposed extrinsic factors that act as triggers or predisposing are recent viral infection, hyperhomocysteinemia, and cervical trauma, including both penetrating and nonpenetrating traumas, or even minor mechanical trauma [10, 16, 17].
There are vascular risk factors connected to ICAD, especially in individuals over 50 years of age. A study showed an association with coronary heart disease (33%), hypertension (57%), and hypercholesterolemia (29%) , also mentioned history of smoking (45%) and history of migraine (21%) as risk factors [3, 16].
Episodes of stroke in ICAD reflect ischemia caused by the reduction of cerebral blood flow due to stenosis by an intramural hematoma or arterial occlusion by an embolization of a local thrombus, resulting in ischemic stroke or transient ischemic attack (TIA) of the brain or optic nerve [3, 4, 18-20].
Amaurosis may occur with disease of the carotid artery, but very rarely with simultaneous ipsilateral cerebral stroke . Some medical authors have suggested that artery-to-artery embolism stemming from a thrombus originated in the injured intima is the primary source of stroke. However, other experts speculate that the hemodynamic process (resulting in stenosis) plays a particularly crucial role [3, 22, 23], the latter mechanism being the less frequent (5%) .
Therefore, we examine a case involving permanent visual impairment and contralateral hemiparesia as a consequence of embolism originated of trauma-induced ICAD.
- Top of page
- Key Clinical Message
- Case Study
- Conflict of Interest
Traumatic ICAD (TICAD) is a rare and serious cause of embolic stroke in young patients. The basic pathophysiological cause of the dissection is the elongation of the artery produced by a mechanism of hyperextension-rotation or flexion-distraction . Only 10% of cases have immediate symptoms and, unlike our patient, most clinical signs usually occur within the first 24 h of the occurrence of the trauma [25, 26].
Traumatic ICAD is suspected and diagnosed when neurological symptoms occur unexpectedly after a trauma. TICAD evolves into stroke in 80% of cases within the first week of the trauma. The common cause of stroke is arterial thrombosis resulting in permanent neurological deficits, with a mortality rate approaching 40% .
In general terms, clinical findings are different when traumatic and spontaneous cases of ICAD are compared. With TICAD, the cerebral ischemic symptoms are the most common clinical manifestations, as is seen in the case of our patient. With spontaneous ICAD, unilateral headache (65–68%) and Horner's syndrome (28–41%) are the symptoms most commonly experienced [2, 4, 22, 27, 28].
Our patient displayed permanent right monocular blindness and left motor-sensory deficit as a result of ICAD following a trauma. In the clinical course of the patient's illness we can appreciate that the signs and symptoms started within 48 h after the cervical trauma (ICAD). As Biousse's study of 146 cases of extracranial ICAD shows us, the ophthalmological symptoms of patients occurred from the first hour until day 31, whereas patients with ischemic stroke presented symptoms occurring within the first up until the second week .
Intracranial ICAD differs from extracranial courses in two different clinical ways: one occurs by way of a subarachnoid hemorrhage and the other presents with headache and/or symptoms associated with ischemic stroke due to cortical stroke, or, as in our case, subcortical stroke, and is produced from arterial occlusion of an embolus (thromboembolic events), or hemodynamic alterations that lead to ischemic stroke in a border zone, which was not observed in the imaging studies in our case (Fig. 1) [19, 24]. According to the literature, ICAD occurs with ischemic stroke in 80–90% of cases [3, 28], TIA in 15–16%, amaurosis fugax in 3%, and ischemic optic neuropathy in 4% .
The factors influencing the severity and extent of stroke are collateral circulation and spontaneous recanalization of the artery [30, 31]. Through ultrasound of the internal carotid artery, Nedeltchev et al. demonstrated that spontaneous complete arterial recanalization was 16% at 1 month, 50% at 3 months, and 60% at 6–12 months. The occurrence of local symptoms and signs only at presentation were independently associated with complete recanalization [31, 32].
The visual disturbance seen in our patient was classified as a case of posterior ischemic optic neuropathy (PION) because of the observed symptoms, including the permanent right amaurosis and normal results of ocular fundus examination; findings were consistent with the data described in studies by Hayreh , where 42 patients with PION had amaurosis and normal ocular fundus examination results.
Cases of PION, according to etiology, are divided into three types: arteritic, nonarteritic, and postsurgical. Our patient was categorized as the nonarteritic form, where there is an association with a variety of diseases, among which are cerebrovascular disease, occlusive carotid disease, and ICAD, among many others [34, 35]. PION produced by an occlusion of the central retinal artery (CRA) is rare (1%) [27, 28, 36], and even then, it is in the joint presence of cerebral infarction and PION, as it is in the case of this particular patient. Therefore, there have been no well-documented cases, so far .
In regard to the mechanism of infarction, it is necessary to establish whether it is the result of an embolic occlusion or a hemodynamic disorder. Thus, we have conducted an analysis of the literature. Two studies involving a total of 248 and 267 patients with ICAD showed that only 5–11% of brain infarctions were the result of a hemodynamic mechanism, while most were caused by embolic events [2, 23]. A retrospective cohort study of 141–143 cases of ICAD reported similar results: thromboembolism (cortical, striatal-capsular, and lacunar) and no hemodynamic infarction was the essential mechanism of stroke. Similar to our case, these studies found that the largest number of infarcts were located in the area of the MCA (99%) (Figs. 1 and 2). Five percent were lacunar, and, as in previous studies, 5% of infarctions were hemodynamic in origin [3, 12, 23].
Generally, it has been established that higher cortical infarcts or those subcortical to 15 mm (as in our case) are embolic in origin . A study that included 40 patients with 65 ICAD found that 52% of infarctions were cortical and 38% were subcortical. All were caused by an artery-to-artery embolism .
In addition to MCA infarction, the case of our patient involves other vascular areas, namely, the area of the CRA. In one study, it was found that 0.5% of ischemic stroke patients (3 of 615 cases) showed a neurological deficit similar to our patient's, which they called optico-cerebral syndrome (OCS). They referred to OCS as monocular blindness (amaurosis), accompanied by contralateral motor deficits (hemiparesis). Unlike our case, the three patients identified in this study suffered from a hemodynamic disorder (iatrogenic and postural hypotension), which caused infarctions located in border zone, between the MCA and anterior cerebral artery (ACA) . In accordance with the aforementioned, we can say that our patient had an OCS (due to the presence of amaurosis and contralateral motor-sensory deficit). However, unlike the cases reported in the literature, with the MR images (Figs. 1 and 2), we can observe the presence of cortical and subcortical infarction greater than 15 mm in the MCA territory, suggesting an embolic event.
It is well known that the emboli originating from dissection of the carotid artery can occlude the ophthalmic artery without generating any visual deficit, because there is collateral vascular support throughout the posterior ciliary arteries, which prevents ischemia [33, 39, 40]. Thus far, the permanent monocular blindness in our patient has been attributed to an embolus occluding the CRA . CRA occlusion is caused by an artery-to-artery embolism. However, a hemodynamic condition may also occur . The CRA irrigates the posterior region of optic nerve and, when occluded, produces permanent monocular blindness, yet ocular fundus examination is usually normal, at first [28, 33, 41]. According to the literature, all patients with nonarteritic PION, carotid artery disease, and history of stroke (with or without carotid artery disease) had significantly increased risk of poor visual test results .
In the medical literature, we have found seven cases of ischemic optic neuropathy coinciding with cerebral infarction, three of which were previously discussed and whose etiology, unlike our case, was due to arterial hypotension. In 1990, Rivkin et al. reported a case of PION with ICAD followed 2 days later by a massive stroke. This case, similar to ours, was attributed to an embolus originating from the carotid artery (artery-to-artery embolism). However, ICAD in this particular case, was not caused by trauma, as it was in our patient's case [21, 35].
In 1989, Newman et al. reported a case of ICAD that produced a lesion of the MCA and ACA. In contrast to our patient, this case showed edema of the retina and optic nerve head (anterior ischemic optic neuropathy). The ischemic cause attributed in this case was also embolic [21, 39]. Bogousslavsky et al.  reported two cases of PION with stroke but did not manage to get the details of each case.
In conclusion, according to many published works, we can show that the amaurosis and subcortical infarction of our patient is the product of the embolic occlusion of two vascular areas (ACM and CRA). This is the only reported case of optico-cerebral syndrome (MCA infarction plus NOIP) due to TICAD. The most likely mechanism of infarction was the formation of an embolus (artery to artery), as is substantiated by the imaging studies.
With regard to treatment, there are several options that aim to reduce the extent of neurological deficit and restore cerebral circulation, including thrombolysis, antithrombotic therapy, endovascular management, and surgery (open repair of the carotid artery) .
There are no studies on thrombolysis in TICAD. The only data come from a meta-analysis and a multicentric study in spontaneous carotid-vertebral artery dissection (CVAD), and the results are contradictory. Therefore, Zinkstok et al. conducted a systematic search of the literature on intravenous and intraarterial thrombolysis in CVAD. They obtained data of 180 patients, 22 retrospective series, and 14 case reports. Intravenous thrombolysis was performed in 67% of cases and intraarterial thrombolysis was performed in 33%. The follow-up period was 3 months, the rate of symptomatic intracranial hemorrhage was 3.1%, and mortality was 8.1%. Outcomes were dependent on the severity of stroke, 41% of patients had excellent results, thus concluding that the benefit of thrombolysis in CVAD is similar to that observed in other stroke etiologies . In contrast, the CADISP study (cervical artery dissection and ischemic stroke patients) of 660 patients with ischemic stroke due to cervical dissection, where 11% (68 patients) received intravenous thrombolysis, demonstrated that this treatment was associated with no significant increase in intracranial bleeding, and no benefit of thrombolysis was found . Despite these conflicting results, thrombolysis is safe and should be offered to patients with ICAD. Although our patient met criteria for thrombolysis, it was not possible to implement due to a lack of alteplase (rt-PA) at our hospital.
There is controversy over the use of antithrombotic therapy in ICAD. With spontaneous ICAD, the most commonly used regimen is intravenous heparin followed by warfarin for at least 3 months. There is some evidence that antiplatelet agents might be associated with better neurological outcomes in patients with traumatic dissection .
Anticoagulation is preferred to antiplatelet agents when there is severe stenosis, arterial occlusion, or pseudoaneurysm, whereas antiplatelet therapy is preferred in cases of large infarcts, intracranial dissections, high risk of bleeding, or inadequate collateral circulation, criteria which were not met in our case. Therefore, it was decided to administer oral anticoagulants even though the available evidence does not show superiority of one therapy over the other.
We can see that a Cochrane review found no randomized controlled studies comparing oral anticoagulants to antiplatelet agents in ICAD. Outcomes are from 36 observational studies that showed no significant difference in mortality or recurrent ischemic stroke. Symptomatic intracranial hemorrhage (0.8%) and extracranial bleeding (1.6%) occurred only in the anticoagulation group but did not reach significant difference . The results of the nonrandomized study in progress at the CADISS arm (cervical artery dissection stroke study) comparing antiplatelet agents and anticoagulants in the prevention of recurrent ischemic stroke in patients with CVAD showed no evidence of superiority between anticoagulation and antiplatelet therapy in terms of stroke recurrence. However, the results of randomized controlled studies are required .
To date, there are no randomized controlled studies of the use of endovascular therapy in ICAD. Nevertheless, based on reports of its effectiveness from small case series, it should be recommended in the following circumstances: persistent symptoms despite antithrombotic therapy, secondary aneurysms of dissection that expand, and with compromised cerebral circulation aneurysms, conditions which were not present in our patient.